Supplementary Data from Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial

Autor: Eric Rohren, Homer Macapinlac, Eugenie Kleinerman, Gregory Ravizzini, Funda Meric-Bernstam, David S. Hong, Sant Chawla, Robert S. Benjamin, Joseph A. Ludwig, Neeta Somaiah, Najat C. Daw, Vinod Ravi, Winston W. Huh, Kenneth Hess, Kalevi Kairemo, Pete M. Anderson, Vivek Subbiah

Supplementary file: Previous therapies, Overall survival S1 : Prior therapies of patients with osteosarcoma enrolled on the Radium 223 trial. Supplementary Table S2: Adverse events in patients with osteosarcoma enrolled on the Radium 223 trial. Suppl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89ecdfee1a6ce2c4fe89fc0211b59635
https://doi.org/10.1158/1078-0432.22472565.v1

Supplementary Data from Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

Autor: Gregory Ravizzini, Satoshi Matsushima, Yuichi Funase, Eri Nakamura, Masamichi Kajita, Tadashi Matsuura, Hirokazu Satoh, Fumiko Nomura, Mary Johansen, Timothy Madden, Ruth Ann Subach, Takeaki Suzuki, Jason Roszik, Jose Gonzalez, Elmer Santos, Dao Le, Shubham Pant, David S. Hong, Funda Meric-Bernstam, Homer Macapinlac, Holly Liu, Carlos Gonzalez-Lepera, Catherine Wheeler, David Wages, Asa McCoy, Osama Mawlawi, William Erwin, Vivek Subbiah

Supplemental files for "Phase 1 Study of P-cadherin-Targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors" Subbiah V et al.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95071a111f84f2a1837002a47b5e95bd
https://doi.org/10.1158/1078-0432.22477688.v1

Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?

Autor: Homer Macapinlac, Elba Etchebehere, Eric M. Rohren, Ana Emília Brito, John Araujo, Kalevi Kairemo

Publikováno v: Radiologia Brasileira, Vol 52, Iss 1, Pp 33-40
Radiologia Brasileira v.52 n.1 2019
Radiologia Brasileira
Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR)
instacron:CBR

Objective: To determine whether an interim 18F-fluoride positron-emission tomography/computed tomography (PET/CT) study performed after the third cycle of radium-223 dichloride (223RaCl2) therapy is able to identify patients that will not respond to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da518aaf369fb9fada91b45f3979f63e
https://doi.org/10.1590/0100-3984.2017.0178

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib

Autor: Ajalaya Teyateeti, Armeen Mahvash, James Long, Mohamed Abdelsalam, Rony Avritscher, Ahmed Kaseb, Bruno Odisio, Gregory Ravizzini, Devaki Surasi, Achiraya Teyateeti, Homer Macapinlac, Srinivas Cheenu Kappadath

Publikováno v: World Journal of Gastroenterology

BACKGROUND Impressive survival outcome of our previous study in unresectable hepatocellular carcinoma (HCC) patients undergoing yttrium-90 glass microspheres transarterial radioembolization (TARE) with/without sorafenib according to individuals’ di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d484461cc94f60e1c026f819c4633e
https://pubmed.ncbi.nlm.nih.gov/35068861

Is interim

Autor: Elba, Etchebehere, Ana Emília, Brito, Kalevi, Kairemo, Eric, Rohren, John, Araujo, Homer, Macapinlac

Publikováno v: Radiologia Brasileira

Objective To determine whether an interim 18F-fluoride positron-emission tomography/computed tomography (PET/CT) study performed after the third cycle of radium-223 dichloride (223RaCl2) therapy is able to identify patients that will not respond to t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::af12dff540d6c6161846b0057eee2e8a
https://pubmed.ncbi.nlm.nih.gov/30804613